• レポートコード:D0804-16538 • 出版社/出版日:GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態:英語、PDF、109ページ • 納品方法:Eメール • 産業分類:医薬品・治療 |
Single User | ¥487,200 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥730,800 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、腎臓用治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。腎臓用治療薬の種類別市場規模(経口、注射)、用途別市場規模(病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報(販売量、市場シェア、製品概要、SWOT分析):Mylan、Dava Pharmaceuticals、Bausch Health Companies、Roche Holding、Fresenius、Endo International、Cardinal Health、Apotex ・地域別グローバル市場分析 2015年-2020年 ・腎臓用治療薬の北米市場(アメリカ、カナダ、メキシコ) ・腎臓用治療薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・腎臓用治療薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・腎臓用治療薬の南米市場(ブラジル、アルゼンチン) ・腎臓用治療薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:経口、注射 ・用途別分析:病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Renal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Renal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Renal Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Renal Drugs market has been segmented into:
Oral
Injections
By Application, Renal Drugs has been segmented into:
Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Renal Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Renal Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Renal Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Renal Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Renal Drugs Market Share Analysis
Renal Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Renal Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Renal Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Renal Drugs are:
Mylan
Dava Pharmaceuticals
Bausch Health Companies
Roche Holding
Fresenius
Endo International
Cardinal Health
Apotex
Among other players domestic and global, Renal Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Renal Drugs Market Overview
1.1 Product Overview and Scope of Renal Drugs
1.2 Classification of Renal Drugs by Type
1.2.1 Global Renal Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Renal Drugs Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injections
1.3 Global Renal Drugs Market by Application
1.3.1 Overview: Global Renal Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacy
1.3.6 Others
1.4 Global Renal Drugs Market by Regions
1.4.1 Global Renal Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Renal Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Renal Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Renal Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Renal Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Renal Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Renal Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Mylan
2.1.1 Mylan Details
2.1.2 Mylan Major Business
2.1.3 Mylan SWOT Analysis
2.1.4 Mylan Product and Services
2.1.5 Mylan Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dava Pharmaceuticals
2.2.1 Dava Pharmaceuticals Details
2.2.2 Dava Pharmaceuticals Major Business
2.2.3 Dava Pharmaceuticals SWOT Analysis
2.2.4 Dava Pharmaceuticals Product and Services
2.2.5 Dava Pharmaceuticals Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bausch Health Companies
2.3.1 Bausch Health Companies Details
2.3.2 Bausch Health Companies Major Business
2.3.3 Bausch Health Companies SWOT Analysis
2.3.4 Bausch Health Companies Product and Services
2.3.5 Bausch Health Companies Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Holding
2.4.1 Roche Holding Details
2.4.2 Roche Holding Major Business
2.4.3 Roche Holding SWOT Analysis
2.4.4 Roche Holding Product and Services
2.4.5 Roche Holding Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fresenius
2.5.1 Fresenius Details
2.5.2 Fresenius Major Business
2.5.3 Fresenius SWOT Analysis
2.5.4 Fresenius Product and Services
2.5.5 Fresenius Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Endo International
2.6.1 Endo International Details
2.6.2 Endo International Major Business
2.6.3 Endo International Product and Services
2.6.4 Endo International Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cardinal Health
2.7.1 Cardinal Health Details
2.7.2 Cardinal Health Major Business
2.7.3 Cardinal Health Product and Services
2.7.4 Cardinal Health Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Apotex
2.8.1 Apotex Details
2.8.2 Apotex Major Business
2.8.3 Apotex Product and Services
2.8.4 Apotex Renal Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Renal Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Renal Drugs Players Market Share
3.2.2 Top 10 Renal Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Renal Drugs Revenue and Market Share by Regions
4.2 North America Renal Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Renal Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Renal Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Renal Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Renal Drugs Revenue and Growth Rate (2015-2020)
5 North America Renal Drugs Revenue by Countries
5.1 North America Renal Drugs Revenue by Countries (2015-2020)
5.2 USA Renal Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Renal Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Renal Drugs Revenue and Growth Rate (2015-2020)
6 Europe Renal Drugs Revenue by Countries
6.1 Europe Renal Drugs Revenue by Countries (2015-2020)
6.2 Germany Renal Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Renal Drugs Revenue and Growth Rate (2015-2020)
6.4 France Renal Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Renal Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Renal Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Renal Drugs Revenue by Countries
7.1 Asia-Pacific Renal Drugs Revenue by Countries (2015-2020)
7.2 China Renal Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Renal Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Renal Drugs Revenue and Growth Rate (2015-2020)
7.5 India Renal Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Renal Drugs Revenue and Growth Rate (2015-2020)
8 South America Renal Drugs Revenue by Countries
8.1 South America Renal Drugs Revenue by Countries (2015-2020)
8.2 Brazil Renal Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Renal Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Renal Drugs by Countries
9.1 Middle East & Africa Renal Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Renal Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Renal Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Renal Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Renal Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Renal Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Renal Drugs Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injections Revenue Growth Rate (2015-2025)
11 Global Renal Drugs Market Segment by Application
11.1 Global Renal Drugs Revenue Market Share by Application (2015-2020)
11.2 Renal Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Drug Stores Revenue Growth (2015-2020)
11.6 Online Pharmacy Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Renal Drugs Market Size Forecast (2021-2025)
12.1 Global Renal Drugs Market Size Forecast (2021-2025)
12.2 Global Renal Drugs Market Forecast by Regions (2021-2025)
12.3 North America Renal Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Renal Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Renal Drugs Revenue Market Forecast (2021-2025)
12.6 South America Renal Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Renal Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Renal Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Renal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Renal Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Renal Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Renal Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Mylan Corporate Information, Location and Competitors
Table 7. Mylan Renal Drugs Major Business
Table 8. Mylan Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Mylan SWOT Analysis
Table 10. Mylan Renal Drugs Product and Solutions
Table 11. Mylan Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Dava Pharmaceuticals Corporate Information, Location and Competitors
Table 13. Dava Pharmaceuticals Renal Drugs Major Business
Table 14. Dava Pharmaceuticals Renal Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Dava Pharmaceuticals SWOT Analysis
Table 16. Dava Pharmaceuticals Renal Drugs Product and Solutions
Table 17. Dava Pharmaceuticals Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bausch Health Companies Corporate Information, Location and Competitors
Table 19. Bausch Health Companies Renal Drugs Major Business
Table 20. Bausch Health Companies Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Bausch Health Companies SWOT Analysis
Table 22. Bausch Health Companies Renal Drugs Product and Solutions
Table 23. Bausch Health Companies Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Holding Corporate Information, Location and Competitors
Table 25. Roche Holding Renal Drugs Major Business
Table 26. Roche Holding Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Roche Holding SWOT Analysis
Table 28. Roche Holding Renal Drugs Product and Solutions
Table 29. Roche Holding Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Fresenius Corporate Information, Location and Competitors
Table 31. Fresenius Renal Drugs Major Business
Table 32. Fresenius Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 33. Fresenius SWOT Analysis
Table 34. Fresenius Renal Drugs Product and Solutions
Table 35. Fresenius Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Endo International Corporate Information, Location and Competitors
Table 37. Endo International Renal Drugs Major Business
Table 38. Endo International Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Endo International SWOT Analysis
Table 40. Endo International Renal Drugs Product and Solutions
Table 41. Endo International Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Cardinal Health Corporate Information, Location and Competitors
Table 43. Cardinal Health Renal Drugs Major Business
Table 44. Cardinal Health Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Cardinal Health SWOT Analysis
Table 46. Cardinal Health Renal Drugs Product and Solutions
Table 47. Cardinal Health Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Apotex Corporate Information, Location and Competitors
Table 49. Apotex Renal Drugs Major Business
Table 50. Apotex Renal Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Apotex SWOT Analysis
Table 52. Apotex Renal Drugs Product and Solutions
Table 53. Apotex Renal Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Renal Drugs Revenue (Million USD) by Players (2015-2020)
Table 55. Global Renal Drugs Revenue Share by Players (2015-2020)
Table 56. Global Renal Drugs Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Renal Drugs Revenue Market Share by Regions (2015-2020)
Table 58. North America Renal Drugs Revenue by Countries (2015-2020)
Table 59. North America Renal Drugs Revenue Market Share by Countries (2015-2020)
Table 60. Europe Renal Drugs Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Renal Drugs Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Renal Drugs Revenue by Countries (2015-2020)
Table 63. South America Renal Drugs Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Renal Drugs Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Renal Drugs Revenue Market Share by Countries (2015-2020)
Table 66. Global Renal Drugs Revenue (Million USD) by Type (2015-2020)
Table 67. Global Renal Drugs Revenue Share by Type (2015-2020)
Table 68. Global Renal Drugs Revenue Forecast by Type (2021-2025)
Table 69. Global Renal Drugs Revenue by Application (2015-2020)
Table 70. Global Renal Drugs Revenue Share by Application (2015-2020)
Table 71. Global Renal Drugs Revenue Forecast by Application (2021-2025)
Table 72. Global Renal Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Renal Drugs Picture
Figure 2. Global Renal Drugs Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injections Picture
Figure 5. Renal Drugs Revenue Market Share by Application in 2019
Figure 6. Hospital Pharmacy Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Drug Stores Picture
Figure 9. Online Pharmacy Picture
Figure 10. Others Picture
Figure 11. Global Renal Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Renal Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Renal Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Renal Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Renal Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Renal Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Renal Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Renal Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Renal Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players Renal Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Renal Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Renal Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global Renal Drugs Revenue Market Share by Regions in 2018
Figure 25. North America Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America Renal Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America Renal Drugs Revenue Market Share by Countries in 2019
Figure 32. USA Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe Renal Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Renal Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Renal Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Renal Drugs Revenue Market Share by Countries in 2019
Figure 44. China Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America Renal Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America Renal Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Renal Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Renal Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Renal Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global Renal Drugs Revenue Share by Type (2015-2020)
Figure 60. Global Renal Drugs Revenue Share by Type in 2019
Figure 61. Global Renal Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global Oral Revenue Growth Rate (2015-2020)
Figure 63. Global Injections Revenue Growth Rate (2015-2020)
Figure 64. Global Renal Drugs Revenue Share by Application (2015-2020)
Figure 65. Global Renal Drugs Revenue Share by Application in 2019
Figure 66. Global Renal Drugs Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Pharmacy Revenue Growth Rate (2015-2020)
Figure 68. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Drug Stores Revenue Growth Rate (2015-2020)
Figure 70. Global Online Pharmacy Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Renal Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Renal Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Renal Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Renal Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe Renal Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Renal Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America Renal Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Renal Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel